Maridebart Cafraglutide
4 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Maridebart Cafraglutide for atherosclerosis | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Maridebart Cafraglutide for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Maridebart Cafraglutide for obesity | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 7 |
| Maridebart Cafraglutide for overweight | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |